Thomas Kent Insider Trade for 1,300 Shares of Tekla Life Sciences Investors (HQL); Profile of 2 Analysts Covering ShawCor Ltd. (TSE:SCL)

Among 2 analysts covering Shawcor Ltd (TSE:SCL), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Shawcor Ltd had 5 analyst reports since August 7, 2015 according to SRatingsIntel. As per Friday, August 7, the company rating was maintained by TD Securities. BMO Capital Markets maintained the shares of SCL in report on Monday, August 10 with “Outperform” rating. The stock has “Sector Perform” rating by RBC Capital Markets on Friday, August 7. See ShawCor Ltd. (TSE:SCL) latest ratings:

Thomas Kent is the director of Tekla Life Sciences Investors. He not a long ago acquired 1,300 shares in the firm with the purchase value amounting to approx. $27,348 US Dollars. This number is according to the filing revealed price of $21.0 of a share. Thomas Kent now indirectly has rights to 0 shares. He also directly has rights to 1300 shares. In total he holds a stake of 0.01%. This sudden trade was reported on January 29, 2018 and is obtainable online on the (SEC)’s website.

Since August 7, 2017, it had 0 buys, and 7 insider sales for $2.34 million activity. On Monday, August 14 the insider STEPAN F QUINN JR sold $1.19M. 1,500 shares valued at $122,400 were sold by PACHOLEC FRANK on Friday, September 15. $713,633 worth of ShawCor Ltd. (TSE:SCL) shares were sold by STEPAN F QUINN. $51,783 worth of ShawCor Ltd. (TSE:SCL) was sold by Behrens Scott R.. Shares for $67,144 were sold by Boyce Michael Ross on Friday, August 25.

Investors sentiment decreased to 1.03 in Q3 2017. Its down 0.38, from 1.41 in 2017Q2. It turned negative, as 23 investors sold ShawCor Ltd. shares while 56 reduced holdings. 21 funds opened positions while 60 raised stakes. 13.94 million shares or 0.54% more from 13.86 million shares in 2017Q2 were reported. Ameriprise Inc reported 0.01% in ShawCor Ltd. (TSE:SCL). 15,787 are held by American Interest Group Inc. Voya Invest Mgmt Limited Liability has 27,518 shares for 0% of their portfolio. Spark Mngmt Ltd Limited Liability Company invested in 4,300 shares or 0.02% of the stock. Victory Mngmt holds 0% or 2,363 shares. Personal Cap Advisors Corporation reported 117,790 shares or 0.19% of all its holdings. 2,559 were reported by First Citizens Comml Bank And Company. The New Jersey-based Systematic Fin Mgmt Lp has invested 0.03% in ShawCor Ltd. (TSE:SCL). 6,759 are owned by Burney Com. Dimensional Fund Advsr Limited Partnership invested 0.04% of its portfolio in ShawCor Ltd. (TSE:SCL). Credit Suisse Ag has invested 0% of its portfolio in ShawCor Ltd. (TSE:SCL). Ameritas Partners owns 1,696 shares or 0.01% of their US portfolio. Whittier Tru invested in 63 shares. Cwm Ltd holds 7 shares. State Of Tennessee Treasury Department holds 17,247 shares.

The stock decreased 1.77% or $0.51 during the last trading session, reaching $28.31. About 44,869 shares traded. ShawCor Ltd. (TSE:SCL) has 0.00% since January 29, 2017 and is . It has underperformed by 16.70% the S&P500.

ShawCor Ltd., an energy services company, provides services and products for the pipeline, pipe services, petrochemical, and industrial divisions of the energy industry worldwide. The company has market cap of $1.98 billion. The firm operates in two divisions, Pipeline and Pipe Services, and Petrochemical and Industrial. It has a 24.81 P/E ratio. The Company’s Bredero Shaw division offers pipe coating, lining, and insulation products; and Canusa-CPS division makes heat shrinkable sleeves, adhesives, and liquid coatings for pipeline joint protection applications.

The stock increased 0.84% or $0.18 during the last trading session, reaching $21.49. About 34,174 shares traded. Tekla Life Sciences Investors (NYSE:HQL) has risen 15.63% since January 29, 2017 and is uptrending. It has underperformed by 1.07% the S&P500.

Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The company has market cap of $454.95 million. The fund invests in public equity markets across the globe. It has a 6.76 P/E ratio. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries.